On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...

With the recently launched Unity system, Alcon aims to allow ophthalmologists to perform vitreoretinal cataract surgery and ...

Secondary IOL implantation improved visual acuity over time across several types of techniques, according to a speaker.At ...

The Global Intraocular Lens Market valued at US $3.9 billion in 2021 and is set to witness a growth rate of ~5-6% in the next 5 years. The global growth in cataract procedures driven by an aging ...

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

Alcon ALC recently received Food and Drug Administration (“FDA”) approval for its TRYPTYR (acoltremon ophthalmic solution) 0.003%. TRYPTYR is indicated for the treatment of the signs and symptoms of ...

About 90% of patients see better after surgery, says a top eye expert. Here's what experts say about the best timing for cataract surgery in both eyes.

This novel intraocular lens is designed to restore dynamic range of vision following cataract surgery, going beyond the capabilities of current presbyopia-correcting lenses. "This IDE approval ...

The Shifamed portfolio company can now begin a traditional feasibility clinical study of the novel intraocular lens. Atia Vision designed it to restore dynamic range of vision folllowing cataract ...

Presbyopia-correcting intraocular lenses (PC-IOLs) offer the potential for spectacle ... Thirty-one patients (62 total) received either Symfony OptiBlue (J&J Vision) or Clareon Vivity (Alcon).